Trial intelligence / Profile preview

Modafinil in Adults with ADHD

NCT00315276Phase 2Completed

Sponsor
Cephalon, Inc.
Start
May 2006
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of modafinil in attention deficit hyperactivity disorder (ADHD), sponsored by Cephalon, Inc.. Started May 2006; status: completed.

02

Drugs

modafinil
03

Conditions

attention deficit hyperactivity disorder (ADHD)

Beyond the preview

Go deeper on NCT00315276.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00315276.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call